Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
33 /100
MEDIUM RISK
Score updated Oct 13, 2026

FDMT — 4D Molecular Therapeutics, Inc. Dilution Risk Tracker

Track FDMT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track FDMT — Get alerts when the score changes →

As of October 13, 2026, 4D Molecular Therapeutics, Inc. (FDMT) has a DilutionWatch DilutionScore of 33/100, rated MEDIUM dilution risk. 4D Molecular Therapeutics, Inc. has a market capitalization of $647.12M, 49.78M shares outstanding, 152 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
35
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for FDMT.
🔔 Track FDMT — Get forecast alerts →

Market Data

Market Cap$647.12M
Shares Outstanding49.78M
Float38.84M
Cash$361.33M
Debt$19.59M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore33/100DilutionWatch score record
Shares Outstanding49.78MVerified float table or market cache
Public Float38.84MVerified float table or market cache
Market Cap$647.12MMarket data cache
Cash Runway25.1 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 16.0% shares (2026Q1 vs prior)
152 institutional holders · 63.39M shares
#1 JANUS HENDERSON GROUP PLC 10.49M shares
#2 GOLDMAN SACHS GROUP INC 8.51M shares
#3 RA CAPITAL MANAGEMENT, L.P. 5.05M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest11.24M
Days to Cover9.3
% of Float28.9%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-18
xbrl XBRL CONVERTIBLE 2022-03-28
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual FDMT Dilution Snapshot

4D Molecular Therapeutics, Inc. (FDMT) has a DilutionScore of 33/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

FDMT's DilutionScore is currently 33/100 (Medium risk), with 4 score changes tracked over 89 days. The score deteriorated from 34/100 (Medium risk).

Period Score Risk Level Duration
Oct 13, 202633/100MEDIUM1 day
Sep 30 – Oct 12, 202634/100MEDIUM13 days
Aug 22 – Sep 29, 202630/100MEDIUM39 days
Aug 14 – Aug 21, 202633/100MEDIUM7 days
Jul 16 – Aug 13, 202630/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

FDMT shares outstanding have increased 2.5% from 51.01M (Mar 2026) to 52.28M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 18, 202652.28M38.84M▲ 6.45%
May 11, 202652.28M36.49M▲ 3.47%
Mar 23, 202651.01M35.26M▲ 0.04%
Mar 21, 202651.01M35.25M▼ 10.65%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track FDMT Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment FDMT files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking FDMT — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for FDMT
FDMT FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.